Navigating the New Normal in the Transportation Industry as the Pandemic Continues

July 17, 2020


The last few months have been unprecedented in world history. The pandemic that is gripping the world has spared no country, culture or corner, and it has highlighted the gaps in many companies’...

Contract Pharma Features Cryoport Growth and Innovation

June 23, 2020

A new Contract Pharma article is all about Cryoport!

Life Sciences in 2020: Biospace Interviews Mark Sawicki on Impending Developments in Cell and Gene Therapy

January 03, 2020

Commercial Officer Mark Sawicki brings more than a sales background to the company: He also holds a Ph.D. in biochemistry and has a distinguished career in global biopharmaceutical development.  


The Future is Now: CCO Mark Sawicki Shares the Effects of New Technology on Cold Chain Logistics in Pharma Manufacturing

December 04, 2019

A new article for Pharma Manufacturing breaks down the technology innovations that are changing cold chain logistics.

Cryoport-Lonza Partnership Featured in Contract Pharma and Biopharma Dive

November 12, 2019

Cryoport is expanding its impact on regenerative medicine development and distribution via a new partnership with Lonza 

New Cryoport Partnerships Featured in Biopharma-Reporter, Contract Pharma, and

October 15, 2019

“The past year has seen Cryoport establish multiple collaborations and expansions of its offering,” says a new article in BioPharma-Reporter, “due to the booming cell and gene therapy space and the...

As More Cell and Gene Therapies Go to Market, Manufacturing Challenges Abound: Cryoport’s Ryan Carpentier Predicts Important Industry Trends in Contract Pharma

September 24, 2019

With just a handful of cell and gene therapies currently on the market, we’ve only seen the tip of the iceberg. 

That’s how Cryoport’s Executive Director of Business Development, Ryan Carpentier,...

Ryan Carpentier Discusses CAR T Therapy Successes and Challenges in Contract Pharma

September 10, 2019

In a new article for Contract Pharma, Cryoport Executive Director of Business Development Ryan Carpentier explains the exciting new opportunities of CAR T-cell immunotherapy, which enables a...

New Cryoport-Vineti Partnership Provides Expanded Supply Chain Services for Cell and Gene Therapy Developers: Outsourcing Pharma, Pharmaceutical Commerce Publications

September 10, 2019

New articles in Outsourcing Pharma and Pharmaceutical Commerce highlight the exciting benefits of the recently announced partnership between Cryoport and Vineti

Life Science Leader Magazine Features Cryoport Board Member Robert Hariri, Stem Cell Research Pioneer and Celularity CEO

August 29, 2019

A new article in Life Science Leader chronicles the incredible achievements of Robert Hariri, M.D., Ph.D. The CEO of Celularity (a Cryoport-supported company) is also a neurosurgeon, a jet aviator, a...

Cryoport’s Technology, Record-Breaking Q2 Earnings Featured in Outsourcing-Pharma

August 14, 2019

A special supply-chain focused edition of Outsourcing-Pharma highlights Cryoport’s new patent-pending technology and excellent Q2 earnings report.

2019 Has Been The Most Significant Year in Cryoport History – And It’s Not Over Yet

June 26, 2019

According to the well-known physics principle, an object in motion tends to stay in motion. That's been especially true at Cryoport over the past six months, as we’ve celebrated one big milestone...

Cryoport President and CEO Jerrell W. Shelton Discusses the ‘Robust Demand’ of the Cell Therapy Market with BioPharma-Reporter

April 22, 2019

Cryoport has experienced remarkable growth in the past year: the company opened facilities in Amsterdam and Livingston, N.J., expanded its animal health services, hired several new employees, and...

Keeping Cell and Gene Therapies Alive in Transit - Technology Networks

March 27, 2019

In recent interview with Technology Networks, Chief Commercial Officer Mark Sawicki discloses the importance of correctly transporting biological materials and how our best in class solutions support...

Cryoport CEO discusses new Global Logistics Centre in Amsterdam - Gasworld

March 06, 2019

Cryoport, a leading provider of temperature-controlled logistics solutions serving multiple markets including biopharmaceutical, IVF and surrogacy and animal health organisations worldwide, has...

Cryoport Expands its Sources of Temperature-Controlled Logistics Solutions - Pharmaceutical Commerce

January 16, 2019

Cryoport has announced a partnership with a Danish firm, Dacos A/S, to provide the full suite of Cryoport offerings. These offerings include their proprietary Cryoport Express® shippers, the...

Cryoport Talks Compliance, Biopharma Expansion, and Brexit - Outsourcing-Pharma

November 13, 2018

Securing the clinical supply chain comes down to the notion of ‘compliance’, which is transitioning from a ‘nice to have’ to a ‘need to have,’ says Mark W. Sawicki, Ph.D., Chief Commercial officer of...

Building an unbreakable Chain of Compliance® - BioPharma Dealmakers

November 06, 2018

Regenerative medicine advanced therapies in the form of cell and gene therapies are breaking new ground, providing patients the potential of treatment, reversal or even cure of serious and...

Cryoport Tackles Market Needs with New NJ Facility - Contract Pharma

November 02, 2018

Cryoport recently unveiled its newest Global Logistics Center, based in Livingston, New Jersey with a ribbon-cutting ceremony attended by several of Cryoport’s clients, local dignitaries and business...

Why the Cold Chain is Striking Hot - ASIA Outlook

October 29, 2018

Find out why the life science temperature-controlled space continues to grow apace in Asia Pacific and how supply chains can keep up with every-complex demands in a recent ASIA Outlook article by ...

Expert Opinion: The Latest Insight on the Life Sciences Supply Chain - ASIA Outlook

October 26, 2018

Mark W. Sawicki, Ph.D., Chief Commercial officer of Cryoport, offers his take on why the life sciences cold chain space continues to grow apace in Asia Pacific and how supply chains can keep up with...

Be The Match BioTherapies, Cryoport Enter Agreement - Contract Pharma

October 04, 2018

Be The Match BioTherapies and Cryoport announced a strategic partnership to deliver end-to-end supply chain services to the cell and gene therapy industry. The collaboration will support both...

Quality Systems for Regenerative Medicine Delivery; Basic Quality Requirements for Distribution - World Pharma Today

August 20, 2018

The emergence of regenerative medicine as a viable therapy class has created an urgency to review and improve upon the current quality systems distribution standards that are employed in support of...

Cryoport, World Courier Ink Logistics Deal for Gene Therapies - Logistics for the Life Sciences

July 17, 2018

Cryoport, Inc. announced that World Courier, a part of AmerisourceBergen, will integrate Cryoport’s full suite of temperature-controlled products into its global network. This integrated platform...

The Chain of Compliance® - Contract Pharma

June 14, 2018

Chain of Compliance® is vital for the Regenerative Medicine Advanced Therapy (RMAT) market which presents a major opportunity for the industry. In a recent Contract Pharma article, Mark W. Sawicki,...

Cryoport® is a trademark of Cryoport, Inc. and used with permission by Cryoport Systems, LLC